Regulation of 25-hydroxyvitamin D3 metabolism in a human promyelocytic leukemia cell line (HL-60): 1,25-Dihydroxyvitamin D3 stimulates the synthesis of 24,25-dihydroxyvitamin D3

https://doi.org/10.1016/0003-9861(86)90069-XGet rights and content

Abstract

The human promyelocytic leukemia cell line HL-60 undergoes macrophage-like differentiation after exposure to 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], the biologically active metabolite of vitamin D3. In the current study, we demonstrate that 1,25(OH)2D3 also regulates 25-hydroxyvitamin D3 [25(OH)D3] metabolism in HL-60 cells. The presence of 1,25(OH)2D3 in the culture medium of HL-60 cells stimulated the conversion of 7–10% of the substrate [25(OH)D3] to a more polar metabolite, which was identified as 24,25-dihydroxyvitamin D3 [24,25(OH)2D3] from the elution positions on sequential HPLC systems and the sensitivity to periodate treatment. The HL-60 subclone HL-60 blast, which is unresponsive to 1,25(OH)2D3 in terms of differentiation, also responded to 1,25(OH)2D3 treatment with the production of 24,25(OH)2D3. Maximal stimulation of 24,25(OH)2D3-synthesis (approximately 7 pmol/5 × 106 cells) in HL-60 cells was noted with a 12-h exposure to 10−9m 1,25(OH)2D3. The ability of vitamin D3 metabolites other than 1,25(OH)2D3 to induce the synthesis of 24,25(OH)2D3 in HL-60 cells was, with the exception of 1α-hydroxyvitamin D3, in correlation with their reported affinities for the specific 1,25(OH)2D3 receptor which is present in HL-60 cells. Treatment of HL-60 cells with phorbol diesters abolished the 1,25(OH)2D3 responsiveness, while treatment with dimethylsulfoxide and interferon γ did not markedly alter the 25(OH)D3 metabolism of HL-60 cells. Small amounts (approximately 1% of substrate) of two 25(OH)D3 metabolites, which comigrated with 5(E)- and 5(Z)-19-nor-10-keto-25-hydroxyvitamin D3 on two HPLC solvent systems, were synthesized by HL-60 cells, independently from 1,25(OH)2D3 treatment or stage of cell differentiation. Our results indicate that 1,25(OH)2D3 influences 25(OH)D3 metabolism of HL-60 cells independently from its effects on cell differentiation.

References (24)

  • H.P. Koeffler

    Blood

    (1983)
  • P.P. Major et al.

    Leuk. Res

    (1981)
  • T. Okabe et al.

    Biochem. Biophys. Res. Commun

    (1985)
  • J.L. Omdahl et al.

    J. Biol. Chem

    (1980)
  • H.L. Henry

    J. Biol. Chem

    (1979)
  • S. Murao et al.

    Cancer Res

    (1983)
  • Z. Bar-Shavit et al.
  • D.J. Mangelsdorf et al.

    J. Cell Biol

    (1984)
  • H. Tanaka et al.

    Biochem. J

    (1982)
  • M. Yoshida et al.

    J. Pharmacobio-Dyn

    (1984)
  • S. Ishizuka et al.
  • S. Ishizuka et al.
  • Cited by (20)

    View all citing articles on Scopus

    This work was supported by USPHS Grants CA26,038, CA-33,936, CA-03,273, and AM-14750.

    1a

    H.R. was supported by the Deutsche Forschungsgemeinschaft (Re 613/1-1).

    1b

    H.P.K. has a Career Development Award from NIH and is a member of the Jonsson Cancer Center.

    View full text